Evidence map›Paper›PMID 42523691›Full record

ReviewFrontiers in immunology2026

Exploring macrophage polarization: biological insights, key laboratory techniques and research perspectives.

Enkhbolor Battumur, John R Clegg, Handan Acar

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Enkhbolor BattumurStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, United States.
John R CleggStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, United States.
Handan AcarStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, United States.

Funding

Enabled by drug delivery: Studying the role of brain-resident and infiltrating myeloid cell phenotype in brain damage associated with inflammatory diseaseR35GM150970 · NIGMS · UNIVERSITY OF OKLAHOMA · PI John R Clegg · 2023 to 2026
$1.7M
NIGMS NIH HHS R35 GM150970
6 · The paper itself

Abstract

Macrophages are key cells of the innate immune system and serve as a first line of defense against invading pathogens while maintaining tissue homeostasis. As highly specialized phagocytic cells, they eliminate pathogens, clear apoptotic and abnormal cells, and coordinate both innate and adaptive immune responses. Under steady state conditions, macrophages remain in a quiescent yet surveillance active state, continuously sensing their microenvironment to preserve tissue integrity without initiating unnecessary inflammatory responses. Tissue resident macrophages, such as microglia in the brain and Kupffer cells in the liver, exhibit functional specialization shaped by local environmental cues, enabling organ specific roles adapted to tissue requirements. Recent advances have improved our understanding of molecular and signaling mechanisms underlying macrophage phenotypic diversity and plasticity. However, macrophage biology remains highly complex due to dynamic responses to temporally and spatially variable microenvironmental signals, as well as the co-existence of heterogeneous pro inflammatory and anti-inflammatory states. In addition, experimental challenges persist, including variability in isolation procedures, difficulties in distinguishing overlapping activation states, lack of universally reliable phenotypic markers, and context-dependent functional variability. Furthermore, discrepancies arising from

Indexed as

Macrophage ActivationMacrophagesAnimalsHumansImmunity, InnateSignal Transductioninnate immunityM1/M2 activationmacrophage plasticitymacrophage polarizationphenotypes switch

Identifiers

PMID42523691
PMCPMC13407363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.